COMPOUND FOR MODULATING RLR, TLR, OAS AND/OR ONCOSTATIN M PATHWAYS, USE THEREOF FOR… Application EP-3939995-A4 European Patent Office 30 Nov 2022
COMPOUND FOR MODULATING RLR, TLR, OAS AND/OR ONCOSTATIN M PATHWAYS, USE THEREOF FOR… Application WO-2020102875-A1 World Intellectual Property Organisation (WIPO) 28 May 2020